Ambiq Micro, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $AMBQ in the last 7 days.
Esaka Fumihide (Chief Executive Officer) sold 108,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $56.89 ($56.15–$58.52, $6.17M total) across 9 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.
Ambiq Micro's CTO and Director, Hanson Scott McLean, sold 55,000 shares at weighted average prices of $59.58 to $60.32, totaling $3.28M. He now directly owns 221,226 shares. The sales occurred in multiple transactions on August 26-27, 2026, according to SEC filings.
Hanson Scott McLean (Chief Technology Officer) sold 55,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $59.69 ($59.58–$60.32, $3.28M total) across 3 trades over 2026-08-26 to 2026-08-27.
Recent AMBQ coverage spans earnings, insider activity and financial news.
In the last 30 days, AMBQ insiders filed 18 SEC Form 4 transactions — no purchases and 18 sales ($10.8M). The most active reporter was Esaka Fumihide, Chief Executive Officer, with 12 filings. 83% of those filings were made under pre-arranged Rule 10b5-1 plans.
The insider sale may signal confidence concerns and could weigh on the stock short term.
Ambiq Micro's CTO and Director, Hanson Scott McLean, sold 55,000 shares at weighted average prices of $59.58 to $60.32, totaling $3.28M. He now directly owns 221,226 shares. The sales occurred in multiple transactions on August 26-27, 2026, according to SEC filings.
Insider sale may signal reduced confidence, potential short-term price pressure.
This is a routine insider sale disclosure, not a new operating or financial catalyst, but it can modestly affect near-term sentiment.
Post-earnings estimate revisions point to improved near-term fundamentals (revenue upside) without a corresponding consensus price-target reset.
alphai scores every news story that mentions AMBQ with an AI model for sentiment and relevance, and aggregates insider trades from Ambiq Micro, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Esaka Fumihide (Chief Executive Officer) sold 108,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $56.89 ($56.15–$58.52, $6.17M total) across 9 trades over 2026-08-31 to 2026-09-02 under a Rule 10b5-1 trading plan.
1 min readAmbiq Micro's CTO and Director, Hanson Scott McLean, sold 55,000 shares at weighted average prices of $59.58 to $60.32, totaling $3.28M. He now directly owns 221,226 shares. The sales occurred in multiple transactions on August 26-27, 2026, according to SEC filings.
1 min readHanson Scott McLean (Chief Technology Officer) sold 55,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $59.69 ($59.58–$60.32, $3.28M total) across 3 trades over 2026-08-26 to 2026-08-27.
1 min readEsaka Fumihide (Chief Executive Officer) sold 13,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $64.39 ($63.29–$65.26, $0.87M total) across 3 trades on 2026-08-14 under a Rule 10b5-1 trading plan.
2 min readAmbiq Micro (NYSE:AMBQ) reported second-quarter results with revenue of $34m, 7.6% above analyst forecasts, and statutory losses of $0.32 per share, 7.6% smaller than expected. Analysts’ 2026 consensus calls for revenue of $135.1m (up from $122.5m) and losses around $1.50 per share, with the price target unchanged at $85.67.
4 min readAmbiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.
4 min readAmbiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.
3 min readAmbiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.
6 min readAmbiq Micro, Inc. (AMBQ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ambiq Reports Second Quarter 2026 Financial Results Delivered record quarterly net sales, increasing approximately 90% year-over-year, driven by strong demand for edge AI solutions Gross profit more than doubled year-over-year on higher net sales and margin expansion Expect third
6 min readAmbiq Micro, a chip designer, plans a secondary listing on the Singapore Exchange, according to CEO Fumihide Esaka, who said it reflects the company’s commitment to Singapore and Asia-Pacific. Ambiq is already listed on the NYSE after raising US$96 million in its July 2025 IPO, according to the report.
2 min read
